Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 EPS, expectations were $1.85. Operator: Thank you for standing by. Welcome to ...

King, like hundreds of thousands of other Americans, takes PrEP – preexposure prophylaxis – daily and by doing so, reduces his risk of contracting HIV through sex by 99%. The club DJ and event ...

A recent funding freeze from USAID has left South Africa's vital HIV and TB treatment programmes in jeopardy. As experts warn ...

President Trump’s pause on aid, and the gutting of the primary aid agency, could jeopardize the health of more than 20 ...

Stock generated 17.13% return as compared to Nifty Pharma which gave investors 57.3% return over 3 year time period. (as of last trading session) ...